Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia

被引:103
|
作者
Gawad, Charles [1 ]
Pepin, Francois [2 ]
Carlton, Victoria E. H. [2 ]
Klinger, Mark [2 ]
Logan, Aaron C. [3 ]
Miklos, David B. [3 ,4 ]
Faham, Malek [2 ]
Dahl, Gary [1 ,4 ]
Lacayo, Norman [1 ,4 ]
机构
[1] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol Stem Cell Transplantat & Canc B, Palo Alto, CA 94304 USA
[2] Sequenta Inc, San Francisco, CA USA
[3] Stanford Univ, Sch Med, Dept Med, Div Blood & Marrow Transplantat, Palo Alto, CA 94304 USA
[4] Stanford Canc Inst, Stanford, CA USA
关键词
MINIMAL RESIDUAL DISEASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR GENE REARRANGEMENTS; V-H; CLONAL EVOLUTION; SOMATIC HYPERMUTATION; RELAPSE; DIAGNOSIS; IG; QUANTIFICATION;
D O I
10.1182/blood-2012-05-429811
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The ability to distinguish clonal B-cell populations based on the sequence of their rearranged immunoglobulin heavy chain (IgH) locus is an important tool for diagnosing B-cell neoplasms and monitoring treatment response. Leukemic precursor B cells may continue to undergo recombination of the IgH gene after malignant transformation; however, the magnitude of evolution at the IgH locus is currently unknown. We used next-generation sequencing to characterize the repertoire of IgH sequences in diagnostic samples of 51 children with B precursor acute lymphoblastic leukemia (B-ALL). We identified clonal IgH rearrangements in 43 of 51 (84%) cases and found that the number of evolved IgH sequences per patient ranged dramatically from 0 to 4024. We demonstrate that the evolved IgH sequences are not the result of amplification artifacts and are unique to leukemic precursor B cells. In addition, the evolution often follows an allelic exclusion pattern, where only 1 of 2 rearranged IgH loci exhibit ongoing recombination. Thus, precursor B-cell leukemias maintain evolution at the IgH locus at levels that were previously underappreciated. This finding sheds light on the mechanisms associated with leukemic clonal evolution and may fundamentally change approaches for monitoring minimal residual disease burden. (Blood. 2012;120(22):4407-4417)
引用
收藏
页码:4407 / 4417
页数:11
相关论文
共 50 条
  • [31] Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia
    Ueno, Hiroo
    Yoshida, Kenichi
    Shiozawa, Yusuke
    Nannya, Yasuhito
    Iijima-Yamashita, Yuka
    Kiyokawa, Nobutaka
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Isobe, Tomoya
    Seki, Masafumi
    Kimura, Shunsuke
    Makishima, Hideki
    Nakagawa, Masahiro M.
    Kakiuchi, Nobuyuki
    Kataoka, Keisuke
    Yoshizato, Tetsuichi
    Nishijima, Dai
    Deguchi, Takao
    Ohki, Kentaro
    Sato, Atsushi
    Takahashi, Hiroyuki
    Hashii, Yoshiko
    Tokimasa, Sadao
    Hara, Junichi
    Kosaka, Yoshiyuki
    Kato, Koji
    Inukai, Takeshi
    Takita, Junko
    Imamura, Toshihiko
    Miyano, Satoru
    Manabe, Atsushi
    Horibe, Keizo
    Ogawa, Seishi
    Sanada, Masashi
    BLOOD ADVANCES, 2020, 4 (20) : 5165 - 5173
  • [32] Results of the prospective EORTC Children Leukemia Group study 58081 in precursor B- and T-cell acute lymphoblastic leukemia
    Domenech, Carine
    Kicinski, Michal
    De Moerloose, Barbara
    Piette, Caroline
    Chahla, Wadih A.
    Kornreich, Laure
    Pasquet, Marlene
    Uyttebroeck, Anne
    Theron, Alexandre
    Poiree, Marilyne
    Arfeuille, Chloe
    Bakkus, Marleen
    Grardel, Nathalie
    Paillard, Catherine
    Freycon, Claire
    Millot, Frederic
    Simon, Pauline
    Philippet, Pierre
    Pluchart, Claire
    Suciu, Stefan
    Rohrlich, Pierre
    Ferster, Alina
    Bertrand, Yves
    Cave, Helene
    HEMASPHERE, 2024, 8 (11):
  • [33] Blinatumomab in Children with MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 11 Cases
    Wang, Yi-Lun
    Chang, Tsung-Yen
    Wen, Yu-Chuan
    Yang, Shu-Ho
    Hsiao, Yi-Wen
    Chiu, Chia-Chi
    Chen, Yu-Chieh
    Hu, Ruei-Shan
    Chen, Shih-Hsiang
    Jaing, Tang-Her
    Hsiao, Chih-Cheng
    HEMATOLOGY REPORTS, 2024, 16 (02) : 347 - 353
  • [34] Posttherapy surveillance of B-cell precursor acute lymphoblastic leukemia - Value of polymerase chain reaction and limitations of flow cytometry
    Kallakury, BVS
    Hartmann, DP
    Cossman, J
    Gootenberg, JE
    Bagg, A
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 111 (06) : 759 - 766
  • [35] DETECTION OF EVOLVING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN ACUTE LYMPHOBLASTIC-LEUKEMIA - A PCR-BASED ASSAY EMPLOYING OVERLAPPING DJ(H) PRIMERS
    NORRIS, MD
    KWAN, E
    HABER, M
    MARSHALL, GM
    LEUKEMIA, 1995, 9 (10) : 1779 - 1782
  • [36] Blinatumomab activity in a patient with Down syndrome B-precursor acute lymphoblastic leukemia
    Wadhwa, Aman
    Kutny, Matthew A.
    Xavier, Ana C.
    PEDIATRIC BLOOD & CANCER, 2018, 65 (02)
  • [37] Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
    Mack, Teresa
    Gianferri, Tommaso
    Niedermayer, Alexandra
    Debatin, Klaus-Michael
    Meyer, Luder H.
    Muench, Vera
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Increased midkine gene expression in childhood B-precursor acute lymphoblastic leukemia
    Hidaka, Hirokazu
    Yagasaki, Hiroshi
    Takahashi, Yoshiyuki
    Hama, Asahito
    Nishio, Nobuhiro
    Tanaka, Makito
    Yoshida, Nao
    Villalobos, Itzel Bustos
    Wang, Yue
    Xu, YinYan
    Horibe, Keizo
    Chen, Sen
    Kadomatsu, Kenji
    Kojima, Seiji
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1045 - 1051
  • [39] Current views of pediatric B cell precursor acute leucoyteic leukemia
    An, Qi
    Qi, Gongjian
    Jin, Mingwei
    MINERVA PEDIATRICA, 2019, 71 (04) : 376 - 379
  • [40] Use of the Polymerase Chain Reaction as a Complementary Method for the Detection of Central Nervous System Involvement in Children and Adolescents with Acute Lymphoblastic Leukemia
    Cancela, Camila S. P.
    Assumpcao, Juliana G.
    Paula, Francisco D. F.
    Murao, Mitiko
    Viana, Marcos B.
    Oliveira, Benigna M.
    CLINICAL LABORATORY, 2018, 64 (1-2) : 205 - 209